Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis
NCT ID: NCT00420875
Last Updated: 2015-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plantar Fasciosis Treatment Using Coblation
NCT00189592
Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
NCT05152173
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
NCT06151197
Percutaneous Needle Tenotomy Associated With Platelet-rich Plasma Injection Platelet-rich Plasma in the Treatment of Refractory Plantar Fasciitis: a Pilot Study of the Effect on Pain and Tolerance
NCT05622279
Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis
NCT01957631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical experience following RF-based plasma microtenotomy has demonstrated excellent success in treating chronic, refractive tendinosis of the lateral epicondyle in the elbow.(9) The investigators reported that this technique was technically simple to perform and was much less invasive than conventional surgery. Patients had a rapid and uncomplicated recovery and reported minimal to no pain 7-10 days following the procedure; their pain relief persisted or improved through 24 months. Magnetic resonance imaging correlated well with clinical results. The RF-based plasma microtenotomy procedure is also being used successfully in tendons in the shoulder, knee, foot and ankle and in the plantar fascia. A randomized controlled study was conducted with the aim of determining whether bRF-based microtenotomy was effective for treating chronic supraspinatus tendinosis (10). Longitudinal postoperative recovery through one year for patients treated using RF-based plasma microtenotomy was compared to patients undergoing subacromial decompression. Both patient groups demonstrated significant improvement after each respective procedure and longitudinal recovery profiles were statistically similar. Early experience using this procedure for foot and ankle tendons, including the Achilles tendon, posterior tibial tendon, peroneal tendon, and plantar fascia revealed over 90% good to excellent results, reflecting the results shown by patients treated for tendinosis in the elbow (11)
Further investigation of optimal placement of this surgical approach into the standard of care treatment paradigm for treating plantar fasciosis and Achilles tendinosis would be beneficial. It is not known whether this RF-based plasma microsurgery might be more optimally placed earlier on within the standard of care treatment algorithm.
The purpose of this study is to determine the magnitude of improvement for pain and functional symptoms over a two year period after enrollment into the registry study in patients presenting with chronic heel pain and undergoing standard of care treatment. Standard of care will include traditional conservative care measures, ESWT, radiofrequency-based plasma microdebridement, scalpel debridement and/or surgical release.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TOPAZ MicroDebrider
The TOPAZ MicroDebrider will be used for patients that fail conservative care. Under sterile conditions in the operating room, patients will be given intravenous sedation (drugs that make you sleepy and unaware of your surroundings) in a hand vein and local anesthetic (drugs to numb the area where the surgical procedure will be done). Depending on the technique used the study doctor may or may not make an incision (cut) about 1 inch long on the side of your foot to expose your tendon. If the study doctor chooses to use the percutaneous method, an incision will not be made. The study doctor will put the tip of the TOPAZ MicroDebrider device (which is about 1/16th of an inch long) into the tendon. A current of energy will be applied on and around the tendon. Steri strips will be placed on the skin to close the area treated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject's history and physical examination pinpoints anatomic origin of heel pain as associated with plantar fasciosis (tenderness with palpation and local pressure over the medial calcaneal tuberosity on passive dorsiflexion) or Achilles tendinosis (tenderness upon palpation and local pressure at the insertion site)
* Subject (or guardian) must sign IRB approved informed consent form
* Subject is willing and able to complete required follow-up
Exclusion Criteria
* Multiple anatomic origins of heel pain in foot to be treated by study
* History or documentation showing Type I and Type II Diabetes Mellitus
* Physical findings and documentation of coagulopathy, infection, tumor or other systemic disease(s)
* History or documentation showing peripheral vascular disease or autoimmune disease
* History or documentation of fibromyalgia
* Subject is currently participating in another drug/device study related to the injured plantar fascia or Achilles tendon
* Pregnant or pregnant suspected subjects prior to treatment
* Subject is incapable of understanding or responding to the study questionnaires
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ArthroCare Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ArthroCare Corporation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Babak Baravarian, DPM
Role: PRINCIPAL_INVESTIGATOR
Foot and Ankle Institute of Santa Monica
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foot Care Physicians
Mesa, Arizona, United States
Foot and Ankle Institute of Santa Monica
Santa Monica, California, United States
Foot and Ankle Clinic of Oakwood
Oakwood, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Aldridge T. Diagnosing heel pain in adults. Am Fam Physician. 2004 Jul 15;70(2):332-8.
Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003 May-Jun;93(3):234-7. doi: 10.7547/87507315-93-3-234.
Yu JS. Pathologic and post-operative conditions of the plantar fascia: review of MR imaging appearances. Skeletal Radiol. 2000 Sep;29(9):491-501. doi: 10.1007/s002560000230.
LeMelle DP, Kisilewicz P, Janis LR. Chronic plantar fascial inflammation and fibrosis. Clin Podiatr Med Surg. 1990 Apr;7(2):385-9.
Schepsis AA, Leach RE, Gorzyca J. Plantar fasciitis. Etiology, treatment, surgical results, and review of the literature. Clin Orthop Relat Res. 1991 May;(266):185-96.
Strash WW, Perez RR. Extracorporeal shockwave therapy for chronic proximal plantar fasciitis. Clin Podiatr Med Surg. 2002 Oct;19(4):467-76. doi: 10.1016/s0891-8422(02)00016-2.
Lewis G, Gatti A, Barry LD, Greenberg PM, Levenson M. The plantar approach to heel surgery: a retrospective study. J Foot Surg. 1991 Nov-Dec;30(6):542-6.
Regan W, Wold LE, Coonrad R, Morrey BF. Microscopic histopathology of chronic refractory lateral epicondylitis. Am J Sports Med. 1992 Nov-Dec;20(6):746-9. doi: 10.1177/036354659202000618.
Goldberg EJ, Abraham E, Siegel I. The surgical treatment of chronic lateral humeral epicondylitis by common extensor release. Clin Orthop Relat Res. 1988 Aug;(233):208-12.
Galliani I, Burattini S, Mariani AR, Riccio M, Cassiani G, Falcieri E. Morpho-functional changes in human tendon tissue. Eur J Histochem. 2002;46(1):3-12. doi: 10.4081/1649.
Nirschl RP, Ashman ES. Elbow tendinopathy: tennis elbow. Clin Sports Med. 2003 Oct;22(4):813-36. doi: 10.1016/s0278-5919(03)00051-6.
Stone PA, McClure LP. Retrospective review of endoscopic plantar fasciotomy. 1994 through 1997. J Am Podiatr Med Assoc. 1999 Feb;89(2):89-93. doi: 10.7547/87507315-89-2-89.
Gould JS. Chronic plantar fasciitis. Am J Orthop (Belle Mead NJ). 2003 Jan;32(1):11-3. No abstract available.
Hammer DS, Adam F, Kreutz A, Rupp S, Kohn D, Seil R. Ultrasonographic evaluation at 6-month follow-up of plantar fasciitis after extracorporeal shock wave therapy. Arch Orthop Trauma Surg. 2005 Feb;125(1):6-9. doi: 10.1007/s00402-003-0591-z. Epub 2003 Oct 3.
Hyer CF, Vancourt R, Block A. Evaluation of ultrasound-guided extracorporeal shock wave therapy (ESWT) in the treatment of chronic plantar fasciitis. J Foot Ankle Surg. 2005 Mar-Apr;44(2):137-43. doi: 10.1053/j.jfas.2005.01.005.
Theodore GH, Buch M, Amendola A, Bachmann C, Fleming LL, Zingas C. Extracorporeal shock wave therapy for the treatment of plantar fasciitis. Foot Ankle Int. 2004 May;25(5):290-7. doi: 10.1177/107110070402500503.
Alfredson H, Lorentzon R. Chronic Achilles tendinosis: recommendations for treatment and prevention. Sports Med. 2000 Feb;29(2):135-46. doi: 10.2165/00007256-200029020-00005.
Hardy RI, James FW, Millard RW, Kaplan S. Regional myocardial blood flow and cardiac mechanics in dog hearts with CO2 laser-induced intramyocardial revascularization. Basic Res Cardiol. 1990 Mar-Apr;85(2):179-97. doi: 10.1007/BF01906971.
Hughes GC, Biswas SS, Yin B, Baklanov DV, Annex BH, Coleman RE, DeGrado TR, Landolfo CK, Landolfo KP, Lowe JE. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol. 2002 Apr 3;39(7):1220-8. doi: 10.1016/s0735-1097(02)01734-5.
Horvath KA, Belkind N, Wu I, Greene R, Doukas J, Lomasney JW, McPherson DD, Fullerton DA. Functional comparison of transmyocardial revascularization by mechanical and laser means. Ann Thorac Surg. 2001 Dec;72(6):1997-2002. doi: 10.1016/s0003-4975(01)03243-x.
Dietz U, Horstick G, Manke T, Otto M, Eick O, Kirkpatrick CJ, Meyer J, Darius H. Myocardial angiogenesis resulting in functional communications with the left cavity induced by intramyocardial high-frequency ablation: histomorphology of immediate and long-term effects in pigs. Cardiology. 2003;99(1):32-8. doi: 10.1159/000068450.
Fisher PE, Khomoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D. Histologic analysis of transmyocardial channels: comparison of CO2 and holmium:YAG lasers. Ann Thorac Surg. 1997 Aug;64(2):466-72. doi: 10.1016/S0003-4975(97)00519-5.
Kohmoto T, DeRosa CM, Yamamoto N, Fisher PE, Failey P, Smith CR, Burkhoff D. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998 May;65(5):1360-7. doi: 10.1016/s0003-4975(98)00236-7.
Kwon HM, Hong BK, Jang GJ, Kim DS, Choi EY, Kim IJ, McKenna CJ, Ritman EL, Schwartz RS. Percutaneous transmyocardial revascularization induces angiogenesis: a histologic and 3-dimensional micro computed tomography study. J Korean Med Sci. 1999 Oct;14(5):502-10. doi: 10.3346/jkms.1999.14.5.502.
Yamamoto N, Gu A, DeRosa CM, Shimizu J, Zwas DR, Smith CR, Burkhoff D. Radio frequency transmyocardial revascularization enhances angiogenesis and causes myocardial denervation in canine model. Lasers Surg Med. 2000;27(1):18-28. doi: 10.1002/1096-9101(2000)27:13.0.co;2-f.
O'Neill CW, Liu JJ, Leibenberg E, Hu SS, Deviren V, Tay BK, Chin CT, Lotz JC. Percutaneous plasma decompression alters cytokine expression in injured porcine intervertebral discs. Spine J. 2004 Jan-Feb;4(1):88-98. doi: 10.1016/s1529-9430(03)00423-6.
Tasto JP, Cummings J, Medlock V, Hardesty R, Amiel D. Microtenotomy using a radiofrequency probe to treat lateral epicondylitis. Arthroscopy. 2005 Jul;21(7):851-60. doi: 10.1016/j.arthro.2005.03.019.
Leitze Z, Sella EJ, Aversa JM. Endoscopic decompression of the retrocalcaneal space. J Bone Joint Surg Am. 2003 Aug;85(8):1488-96. doi: 10.2106/00004623-200308000-00009.
Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am. 2004 Apr;86(4):670-9.
Sharps LS, Isaac Z. Percutaneous disc decompression using nucleoplasty. Pain Physician. 2002 Apr;5(2):121-6.
Singh V, Piryani C, Liao K, Nieschulz S. Percutaneous disc decompression using coblation (nucleoplasty) in the treatment of chronic discogenic pain. Pain Physician. 2002 Jul;5(3):250-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SM-706WW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.